In this week's Talking Tech, Josh Holmes-Bright speaks to the interim CEO of Exscientia - a leading pharma-tech company at the forefront of AI-driven drug discovery. - about how they aim to accelerate the delivery and quality of life-changing therapies to patients worldwide.